Influences of Angiotensin-neprilysin Inhibition on Sympathetic Activity in Heart Failure

NCT03415906 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Difficulties in recruiting patients

Conditions

Heart Failure

Interventions

COMBINATION_PRODUCT: sacubitril+valsartan
DRUG: valsartan

Sponsor

Hannover Medical School

Collaborators

[object Object]